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Abstract
Background: Cardiomyocytes derived from murine embryonic stem (ES) cells possess various membrane currents and
signaling cascades link to that of embryonic hearts. The role of atrial natriuretic peptide (ANP) in regulation of membrane
potentials and Ca
2+ currents has not been investigated in developmental cardiomyocytes.
Methodology/Principal Findings: We investigated the role of ANP in regulating L-type Ca
2+ channel current (ICaL)i n
different developmental stages of cardiomyocytes derived from ES cells. ANP decreased the frequency of action potentials
(APs) in early developmental stage (EDS) cardiomyocytes, embryonic bodies (EB) as well as whole embryo hearts. ANP
exerted an inhibitory effect on basal ICaL in about 70% EDS cardiomyocytes tested but only in about 30% late
developmental stage (LDS) cells. However, after stimulation of ICaL by isoproterenol (ISO) in LDS cells, ANP inhibited the
response in about 70% cells. The depression of ICaL induced by ANP was not affected by either Nv, Nitro-L-Arginine methyl
ester (L-NAME), a nitric oxide synthetase (NOS) inhibitor, or KT5823, a cGMP-dependent protein kinase (PKG) selective
inhibitor, in either EDS and LDS cells; whereas depression of ICaL by ANP was entirely abolished by erythro-9-(2-Hydroxy-3-
nonyl) adenine (EHNA), a selective inhibitor of type 2 phosphodiesterase(PDE2) in most cells tested.
Conclusion/Significances: Taken together, these results indicate that ANP induced depression of action potentials and ICaL is
due to activation of particulate guanylyl cyclase (GC), cGMP production and cGMP-activation of PDE2 mediated depression
of adenosine 39,5 9–cyclic monophophate (cAMP)–cAMP-dependent protein kinase (PKA) in early cardiomyogenesis.
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Introduction
It has long been known that cardiac ICaL is under control of the
atrial natriuretic peptide (ANP), a member of class of polypeptides
that includes also brain natriuretic peptide (BNP) and C-type
natriuretic peptide (CNP) [1,2]. ANP is known to be ontogenetically
expressed very early during development [3] and regulate a variety
of physiological processes affecting cardiovascular homeostasis. It is
preferentially secreted by atrial myocytes under conditions of
tachycardia [2,4]. The regulation through its receptors -ANPR-A
and ANPR-B- which are part of a membrane-bound guanylyl
cyclase complex and a clearance receptor (ANPR-C) [5,6] has
attracted much attention among cardiac physiologists. Recent
studies demonstrate that the genes for all three natriuretic peptide
receptor subtypes are expressed in human heart during development
[7] as well as in ES cell derived cardiomyocytes [8]. ANP is known
to act through direct stimulation of the particulate guanylyl cyclase/
cGMP- as well as through a G protein mediated inhibition of the
adenylyl cyclase/cAMP system [9–11]. However, it still remains
under debate as to whether and how ANP modulates chronotropy
and inotropy of the heart [12]. Several studies reported the negative
inotropic effect induced by ANP, related to intracellular production
of cGMP, activating PKG and altering Ca2+ channels to decrease
intracellular transients [13–15]. However, Lainchbury et al. [16]
reported a positive inotropic effect of ANP. ANP is known to depress
ICaL, however the mechanism of this modulation is still controver-
sial. Gisbert & Fischmeister [17] reported that ANP decreased b-
adrenergic agonist pre-stimulated ICaL and had only a negligible
effects on basal ICaL in frog isolated cardiac cells. While, Tohse
et al [18] detected inhibition of the basal ICaL by ANP via
production of cGMP and activation of PKG in guinea pig
cardiomyocytes. An ANP induced decrease of the basal ICaL was
also reported for guinea pig [19], rat [20], chick embryos, human
atrial and rabbit heart cells [17,21–23]. Moreover, some authors
[24] reported that ANP decreased both basal and cAMP
pre-stimulated ICaL in fetal heart cells and increased ICaL in
human atrial cells [25]. However, the role of ANP in regulating ICaL
in early developmental stages of cardiomyocytes has not been
observed.
The embryonic stem cell-derived cardiomyocytes have been
demonstrated to be a unique tool for functional studies on early
cardiomyogenesis [26,27]. This model of cardiomyocytes expresses
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embryonic heart. Previous studies also indicated that nitric oxide
(NO) is highly expressed in early developmental stages of
cardiomyocytes, and that ICaL was regulated and modulated by
muscarinic agonists in cardiomyocytes through NO-dependent
pathway [26,27].
In the present study, we investigated the effects of ANP (rat ANP
3–28) on ICaL in cardiomyocytes derived from mouse ES cells as
well as isolated myocytes from mouse embryonic hearts. We found
that ANP depressed basal ICaL in early developmental stage and
ISO pre-stimulated ICaL in late developmental stage cardiomyo-
cytes. The mechanism by which ANP inhibits ICaL involves
activation of the pGC/cGMP pathway, and cGMP-stumulation of
PDE2 activity, leading to inhibition of the cAMP/PKA pathway.
Materials and Methods
Cell Culture and ES Cell Differentiation Procedure
The murine embryonic stem cell line D3 was used throughout
this study. Cells were cultivated and differentiated into spontane-
ously beating cardiomyocytes in Dulbecco’s modified Eagle’s
medium (DMEM) (Serva, Heidelberg. Germany) supplemented
with non-essential amino acids, L-glutamine, b-mercaptoethanol
(GIBCO BRL GmbH, Germany), and 15% fetal calf serum (FCS)
(selected batches of GIBCO BRL) [26]. The D3 cell line was
originally established by cultivation of a disaggregated single
blastomere of an eight-cell stage 129/ter Sv mouse embryo on
feeder layer cells in culture medium additionally supplemented with
5000 IU leukemia inhibiting factor(LIF). About 60 drops (20 mlo f
cultivation medium containing 400 cells) were placed on the lids of
10 cm petri dishes filled with phosphate-buffered saline (PBS) and
cultivated for 2 days. Aggregates were then transferred from the
hanging drops into 6 cm non-adhesive bacteriological petri dishes
containing 5 ml cultivation medium and were further cultivated for
5 days (‘7 d’). The resulting embryoid bodies (EBs) were separately
placed into each well of 24 well-microwell plates coated with gelatin.
During further development of the attached EBs cells of
endodermal, ectodermal and mesodermal origin were obtained in
the outgrowths. First spontaneously beating cardiomyocyte clusters
appeared one or two day (7+1/2 d) after plating of EBs in the outer
region of the EB outgrowth. Single cardiomyocytes were prepared
from beating cell clusters by collagenase (see below).
Preparation of Single Cardiomyocytes
Single cardiomyocyte-like cells were isolated at distinct
developmental stages: 1) early developmental stage (EDS) when
first spontaneously contracting clusters of cardiomyocytes ap-
peared (7+1–4 d); 2) late developmental stage (LDS, 7+9–12 d).
The following solutions were used (in mmol/L): a) low Ca
2+
medium: NaCl 120, KCl 5.4, MgSO4 5, Na pyruvate 5, glucose
20, taurine 20, HEPES [N-(2-Hydroxyethyl) piperazine-N9-2-
ethanesulfonic acid] 10, pH 6.9 at 24uC (adjusted with NaOH); b)
enzyme medium: Low Ca
2+ medium supplemented with 1 mg/ml
collagenase (collagenase B, Boehringer Mannheim) and 30 mmol/
L CaCl2; and c) KB medium: KCl 85, K2HPO4 30, MgSO4 5,
EGTA 1, Na2ATP 2, Na pyruvate 5, creatine 5, taurine 20,
glucose 20, pH 7.2 at 24uC (adjusted with NaOH).
Beating areas of EBs were dissociated using a microscalpel under
microscope in a clean air laminar hood. The isolated beating areas
were collected and washed in low Ca
2+ medium for 30 to 60 min at
room temperature. Tissue fragments were then incubated in the
enzyme medium for 20 min at 37uC. The dissociation of tissue was
completed in KB medium by gentle shaking for 20 min and resting
for 40 min at room temperature. The isolated cells were
resuspended in cultivation medium supplemented with 20% FCS
and plated on sterile, gelatin-coated 12612 glass cover slips and kept
in the incubator for 12 to 24 hours at 37uCa n d5 %C O 2.D u r i n g
the first 12 hours of incubation, the isolated cardiomyocytes
attached to the surface of the glass cover slips and started
spontaneous rhythmical contractions. Single embryonic cardiomy-
ocytes were isolated as described previously [28]. All animal
procedures described in this study were performed in adherence
with the G u i d ef o rt h eC a r ea n dU s eo fL a b o r a t o r yA n i m a l spublished by
the US National Institutes of Health (NIH Publication No. 85-23,
revised 1996), with approval from the Institute of Biophysics
Committee on Animal Care. Electrophysiological and immunoflu-
orescence investigations were performed on these cardiomyocytes.
Electrophysiological Measurements
The whole-cell configuration of the patch-clamp technique was
used throughout the study on single cardiomyocytes. The glass
cover slips with attached isolated single cardiac myocytes were
transferred into the recording chamber and continuously super-
fused with extracellular solution E1 (table 1) for measurement of
action potentials and E2 for the measurement of ICaL (table 1).
Membrane potentials were recorded in the current clamp mode
and membrane currents in the voltage-clamp mode using an
Axopatch 200-B amplifier (Axon Instruments, USA). For mea-
surement of ICaL, voltage-clamped cells were held at 240 mV in
order to inactivate the sodium currents, and trains of 20 ms lasting
depolarizing pulses were applied to a test potential of 0 mV at a
frequency of 0.2 Hz. Membrane capacitance was determined
using the acquisition/analysis software program ISO2 (MFK,
Frankfurt, RG). Data were acquired at a sampling rate of 10 kHz,
stored on hard disk and analyzed off-line.
EB and whole embryonic heart action potentials were
monitored with conventional 3 M KCl-filled glass microelectrodes
(10–20 MV) attached to a VF-1 preamplifier (World Precision
Instruments, Sarasota, FL).
Pipettes and Solutions
The solutions used throughout the study are listed in Table 1.
The patch pipettes (2–4 MV resistance when filled with the
Table 1. Internal and external solutions used in the study.
Substances I1 (mM/L) I2 (mM/L) E1(mM/L) E2 (mM/L)
NaCl 0 0 140 120
KCl 50 0 5.4 5
K-aspartate 80 0 0 0
CsCl 0 120 0 0
CaCl2 0 0 1.8 1.8
MgCl2 13 1 1
EGTA 10 10 0 0
HEPES 10 5 10 10
Glucose 0 0 10 0
Mg-ATP 3 5 0 0
TEA* 0 0 0 20
Na-GTP 0 0 0.42 0
I: internal solution; E: external solution.
*TEA indicates: Tetraethylammonium.
pH: I1 was 7.50 adjusted with KOH, I2 was 7.50 adjusted with CsOH at 23uC. E1
and E2 were 7.40 adjusted with NaOH and TEAOH at 23uC, respectively.
doi:10.1371/journal.pone.0008847.t001
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(England) borosilicate glass capillaries using a Zeitz puller (DMZ,
Munich, FRG) and filled with the solution I1 for the measurement
of APs. The internal solution I2 was used for the measurement of
ICaL.C s
+ (in internal solution) and tetraethylammonium (TEA, in
external solution) were used to block most K
+ currents and 4-
Aminopyridine was added to the extracellular solution to minimize
the interference from the transient outward K
+ current (Ito). To
exclude the possible contamination of ICaL by Na-channel current
TTX(10 mM) was added in external solution. The pH of all
solutions was adjusted to 7.4 at a temperature of 37uC. Cells were
constantly superfused using a gravitational perfusion system, the
perfusion rate being approximately 2 ml/min. The chamber
volume was 0.5 ml. The temperature of the bath as well as of the
perfusion solutions was kept constant at 37uC.
RT-PCR and Immunofluorescence Study of ANP
Single cell preparations of EDS cardiomyocytes isolated from
embryo heart were used for the immunocytochemical investigation
of ANP and a-MHC staining. Single cell preparations were fixed
in 4% paraformaldehyde in 0.1 M PBS for 20 minutes. Fixed
samples were washed three times with PBS (pH 7.4). The cells
were incubated with 0.1% triton X-100 for 10 min, followed by
incubation with a-MHC antibody (goat anti mouse IgG) and ANP
antibody (rabbit anti mouse IgG) in 1% BSA PBS for 2 hr and
wash three times at room temperature. Thereafter, cell prepara-
tions were then indirectly immunolabelled with a dilution 1:400 a-
MHC donkey anti-goat antibody (labeled with Rhodamine Red-
X) and ANP bovine anti-rabbit antibody (labeled with FTTC) for
one and half hr at room temperature.
RT-PCR was performed by routine methods on embryo
cardiomyocytes dissected from different developmental stages,
i.e. E8.5d, E12.5 and E15.5 day, using the following specific
primers (forward and reverse, respectively):CCTGTGTA-
CAGTGCGGTGTC, AAGCTGTTGCAGCCTAGTCC.
Reagents
ANP(3–28,1–28), Met (o)
12-ANP, ATP-c-S and forskolin were
purchased from Sigma; KT5823 and EHNA were from
Calbiochem. All other substances used in the study were from
Sigma. ANP 3–28 was used throughout the study, indicated,
otherwise.
Analysis of Data
Averaged results are presented as mean 6 standard error of the
mean (SEM). Statistical analysis was performed using paired and
unpaired Student’s t-test, when more than one experimental
condition was evaluated a Bonferroni correction was performed, p
values of ,0.05 were considered significant. The straight line
connecting control amplitude of peak ICaL prior to ANP
application and after wash-out was used as an estimate for ICaL
run-down. For calculation of the ANP-dependent ICaL depression
the control value was defined as the peak current taken on the line
in the same time-point as the maximal inhibition of ICaL by ANP.
For calculation of basal ICaL stimulation the control ICaL was taken
as the reference value. Current densities are expressed as current
amplitude divided by cell capacitance (pA/pF). To indicate that
the recording of the currents is stable, we also analyzed the holding
currents as indicated by black dots at 0 pA for each experiment.
From the holding currents we know that the leakage of the
currents is very small, so in the present study the leakage
subtraction was not carried out. The results are expressed as
means 6 SEM. Significant differences between groups were
determined by the Student’s t test.
Results
Expression of ANP in Mouse Embryonic Cardiomyocytes
It has previously been reported that ANP is expressed in
cardiomyocytes derived from monkey ES cells [8]. Since nothing
was known in mouse embryonic cardiomyocytes, we examined the
expression of ANP in this preparation. We first sought to detect the
presence of ANP in mouse embryonic cardiomyocytes by double
immunofluorescence staining for ANP (green) and a-MHC (red),
and the results demonstrated that embryo cardiomyocytes contain
ANP in the cytoplasm during all developmental stages (E8.5d,
E12.5d, and E15.5d, Fig. 1A). RT-PCR studies also indicated that
ANP was expressed at the mRNA level in different developmental
stages of mouse embryo heart (Fig. 1B).
Effect of ANP on Action Potentials in Early
Developmental Stage Cardiomyocytes
First evidence for functional effects of ANP on EDS cells was
obtained in current clamp experiments. Fast perfusion of
spontaneously contracting cardiomyocytes derived from ES cells
Figure 1. Expression of ANP in mouse embryonic cardiomyocytes. A: double staining of ANP (left, green) and a-MHC (right, red) in E8.5d (a), E12.5d
(b), and E15.5d (c) cardiomyocytes. B: PCR product of ANP. Lanes indicate 1 marker, 2 E8.5d, 3 E12.5d, and 4 E15.5d, respectively. The scale bar is 10 micron.
doi:10.1371/journal.pone.0008847.g001
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effect, without concomitant hyperpolarization and this effect was
reversible upon washout (Fig. 2A, upper traces). To unequivo-
cally prove the effect of ANP on APs in ES derived
cardiomyocytes, the effect of ANP on APs was also examined
in cardiomyocytes isolated from early developmental mouse
embryonic hearts (E8.5,10.5d), and similar results as in ES cell-
derived cardiomyocyte were obtained, i.e. a reversible decrease
in AP frequency in 16 out of 18 experiments (Fig. 2A, lower
traces). The effects of ANP were not only seen in single cells but
also in integrated preparations, since ANP had also pronounced
inhibitory effects on AP frequency in mouse EDS EBs (Fig. 2B,
upper traces) and mouse whole embryo heart (E8.5d, Fig. 2B,
lower traces). The negative effect of ANP on APs usually was
observed about 20 s after fast perfusion in single cardiomyocytes,
EBs, and even in E8.5d mouse heart. If the effects of ANP were
not washed the APs could be completely inhibited with the time
(Fig. S1B).
ANP Inhibits Basal ICaL in EDS Cardiomyocytes Derived
from ES Cells
The negative chronotropic effect of ANP indicates that ANP
must affect the activity of ion channels. Because ANP did not
exhibit any effect on If and Iks (data not shown) we focused our
interest on the L-type Ca
2+ channel current and examined the
effect of ANP on ICaL in cardiomyocytes derived from ES cells.
The protocols used to measure ICaL was a 20 ms lasting
depolarizing pulse to 0 mV from a holding potential of
240 mV (see Materials and Methods). Fig. 3A shows a typical
experiment in which 20 nM ANP 3–28 induced a pronounced
inhibition of the peak amplitude of ICaL.O na v e r a g e( F i g .3 D ) ,
ANP induced an inhibition of ICaL by 60.3610.1% (n=16,
p,0.05) after application of ANP in about 70% cells tested
(Fig. 3C), which is similar to our previous study (27). The effect
of ANP was always reversible upon washout. The effect of ANP
was not voltage-dependent, since ANP induced propotional
reduction of peak ICaL at all potentials tested (Fig. 3B). Figure
S1 shows concentration-response relation between ANP and
the ICaL. ANP at concentration above 10 nM decreased the
peak current.
It has reported that another type of ANP, ANP 1–28, also has
inhibitory effect on ICaL in rabbit heart cells [18]. To examine if
this type of ANP has the similar effect on ICaL as ANP 3–28 in our
model, equal concentration of ANP1–28 was tested. The results
suggested that ANP1–28 (20 nM) had little effect on basal ICaL in
EDS cells, but increasing its concentration to 50 nM led to a
similar inhibition of ICaL as 20 nM ANP 3–28 (data no shown). As
a negative control, the inactive form of ANP, Met (o)
12-ANP had
no effect on ICaL at concentrations ranging from 10 to 100 nM
(data not shown).
In parallel, the effect of ANP on ICaL was also examined in early
myocytes isolated from mouse embryo heart (E8.5d). Similarly to
Figure 2. Inhibition of spontaneous action potentials by ANP. A: Action potentials recorded from a spontaneously contracting EDS cell
(upper) and an E8.5d cardiomyocyte (lower) in the current clamp mode. The frequency of action potentials was decreased by application of ANP in a
reversible manner. B: action potentials recorded from an early developmental stage EB (upper) and an embryonic 8.5 day heart (lower). As seen in
single EDS and E8.5d cells, application of ANP exerted a negative chronotropic effect that was washable.
doi:10.1371/journal.pone.0008847.g002
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was reduced by 65.468.6% by ANP in embryo heart cells tested
(data not shown, n=16).
ANP Inhibits ISO Pre-Stimulated ICaL in LDS
Cardiomyocytes
Next we tested whether ANP also regulated ICaL in LDS
cardiomyocytes. Although ANP also decreased basal ICaL in
LDS cells (Fig. 4Aa), the effec tw a sm u c hl e s sf r e q u e n ta s
compared to EDS cardiomyocytes, with only about 34% cells
(n=22) which responded to the peptide (Fig. 4Ab). However,
when ICaL was pre-stimulated by ISO (100 nM), adding ANP on
top of ISO induced a pronounced inhibition of ICaL (Fig. 4Ba)
which occurred in about 70% cells (Fig. 4Bb) and averaged
58.6618.6% inhibition (n=8, Fig. 4Bc). This effect was
reversible in most of cells upon washout (Fig. 4Ba & c).Thus,
our data indicate that ANP also regulates ICaL in LDS cells, but,
unlike the EDS cells, its effect requires, or at least is more
prominent after a pre-stimulation of the current by b-adrenergic
receptor.
ATP-c-S Plus Forskolin Block the Depression of ANP on
ICaL in EDS Cardiomyocytes
The above results are reminiscent of the effect of the muscarinic
agonist carbachol (CCh), which was reported in our earlier study
to inhibit basal ICaL in EDS cells but required ISO pre-stimulation
of ICaL to produce its inhibitory effect in LDS cells [27]. One
possible difference between EDS and LDS cells is the higher
intrinsic activation of the cAMP/PKA pathway in the former [27],
pointing to a possible action of ANP on this pathway. In order to
test this hypothesis, the effect of ANP was examined on EDS cells
after pre-stimulation with the adenylyl cyclase activator forskolin
(1 mM in bath solution) or ISO, and in the absence or presence of
2 mM ATP-c-S in the patch pipette solution to block dephos-
phorylation. As shown in Fig. 5Aa, ANP decreased ICaL stimulated
by forskolin, but had no effect when ATP-c-S was present in the
patch-pipette (Fig. 5Ba). On average, the stimulatory effect of
forskolin was not different in the absence (61.467.4%, n=8) and
presence of ATP-c-S (63.668.6%, n=12), but the effect was
irreversible upon washout in the latter case. However, the effect of
ANP on pre-stimulated ICaL was abolished in almost all cells
Figure 3. ANP depresses basal ICaL in EDS cardiomyocytes. A, Typical recording of ICaL from a single cell. Upon application of 20 nM ANP, rat
3–28, basal ICaL was decreased. This effect could be partially reversed by washout. The inset represents currents recorded as indicated by the
mumbers in the time course diagram. B, I/V relationship: ANP decreased peak ICaL without a shift in the I/V relationship. C, percentage of cells
responding to ANP. D, density of peak ICaL.
doi:10.1371/journal.pone.0008847.g003
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of the cAMP/PKA axis.
Role of Gi/o Proteins in the ANP-Mediated Inhibition of ICaL
Since ANP blocks the cAMP/PKA pathway, its effect could be
e i t h e rt h r o u g ha ni n h i b i t i o no fa d e n y l y lc y c l a s evia activation of
pertussis toxin (PTX)-sensitive Gi/o proteins [29–31], or through
cGMP generated by activation of the particulate GC. To test the
former hypothesis, EDS cells were incubated with 1 mg/ml PTX
for 12 hours. Under this condition, application of ANP still
depressed ICaL in 50% of both EDS (Fig. 6Aa and b) and LDS
(data not shown) cells. Thus, the depression of ICaL by ANP was
not related to PTX sensitive Gi/or Go proteins. Fig. 6B shows a
positive control for PTX in LDS cells.
Role of cGMP-Activated PDE2 in the Inhibitory Effect of
ANP on ICaL in EDS Cardiomyocytes
As shown earlier [27], the NO/soluble GC pathway is not
involved in the inhibition of basal ICaL in mouse EDS cells.
However, since the ANP receptor activates the particulate GC,
Figure 4. Effect of ANP on basal and ISO stimulated ICaL in LDS cells. Aa & Ba, time courses of peak ICaL recorded from single LDS cells. Both
basal and ISO pre-stimulated ICaL were strongly depressed by application of ANP. Ab & Bb, percentage of cells responding to ANP. Note that the
percentage of responding cell in EDS is much lower compared to LDS cells. Ac & Bc, current density of peak ICaL.* P ,0.05, **P,0.01 compared with
control, respectively.
doi:10.1371/journal.pone.0008847.g004
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on basal ICa,L. cGMP could inhibit ICaL via either cGMP-
dependent protein kinase (PKG) [32] or via activation of cAMP
hydrolysis via stimulation of the cGMP-stimulated PDE2 [20,33].
To discriminate between these two hypothesis, the effect of ANP
on ICaL was tested in the presence of the PKG inhibitor KT5823
or the PDE2 inhibitor EHNA. As shown in Figure 7A, KT5823
(1 mM) did not eliminate the effect of ANP in EDS cells tested.
Conversely, EHNA (20 mM), which as shown earlier [27]
increased the basal ICaL (by 22.163.3%), blocked the ANP
inhibitory effect on basal ICaL in 94% of EDS cells tested (see also
Fig. 7Ba, Bb, and Bc). Unlike EHNA, the PDE3 inhibitor
milrinone (10 mM) did not block the inhibitory effect of ANP
(20 nM), which still decreased ICaL by 49.469.4% (data not
shown). Taken together, these findings suggest that the decrease of
ICaL by ANP is mediated through an increase of cGMP levels,
Figure 5. Effect of ATP-c-S plus forskolin on ANP induced ICaL inhibition. Aa, time course shows that ANP depressed forskolin pre-
stimulated ICaL, however the depressed effect of ANP on forskolin pre-stimulated ICaL was abolished in the presence of ATP-c-S (Ba). The insets are
traces recorded in the same cells as time courses. Ab & Bb, percentage of cells with or without responding to ANP. Ac & Bc, density of peak ICaL.
*P,0.05 compared with control.
doi:10.1371/journal.pone.0008847.g005
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cAMP breakdown, decrease of PKA levels, and ultimately reduced
phosphorylation of voltage dependent Ca
2+ channels (VDCC) or a
closely associated protein.
In order to prove that the effect of ANP on ICaL is mediated by
cGMP we examined the effect of 8-bromo-cGMP on ICaL in early
developmental cardiomyocytes derived from ES cells as well. As
displayed in figure S2, upon application of 200 mM 8-bromo-
cGMP led to a significant suppression of the L-type Ca
2+ current
and this effect of 8-bromo-cGMP was abolished by pre-treatment
of the cells with EHNA. The experimental results of 8-bromo-
cGMP confirmed that the depression of ANP on ICaL was
mediated by cGMP in early developmental cardiomyocytes.
Discussion
Here, we report that ANP (3–28) exerts negative chronotropic
effect without hyperpolarization in EDS cardiomyocytes derived
Figure 6. PTX did not abolish ANP induced ICaL inhibition. Aa, time course demonstrates that in PTX pre-treated cardiomyocytes derived from
ES cells ANP still inhibited ICaL. Ba, time course of PTX positive control experiment which indicates PTX abolished CCh caused inhibition on ICaL. Ab
and Bb,percentage of cells with or without responding to ANP(Ab) or CCh (Bb). Ac and Bc, density of peak ICaL.* P ,0.05 compared with control.
doi:10.1371/journal.pone.0008847.g006
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probably mediated by a depression of the basal ICaL in EDS
cardiomyocytes and in b-receptor pre-stimulated ICaL in LDS
cardiomyocytes because ANP did not exhibit any effect on both If
and IKs currents in the present study (data not shown). From the
time course of ANP action on ICaL and APs we noted that when
the ICaL was reduced by about 30% of maximal effect by ANP the
negative chronotropic effect occurred, and when the reduction of
the ICaL reached the maximum the APs were completely inhibited
in almost all experiments conducted if washout was not followed
(Fig. S1B). ANP depressed ICaL without an effect on the I/V
relationship, indicating that the degree of ICaL inhibition was
proportional at all potentials, and that the depressing effect of ANP
on ICaL was completely abolished by clamping cAMP or PKA
levels which suggests that ANP is only acting through activation of
the cGMP stimulated PDE2. Indeed, EHNA, the selective PDE2
inhibitor, resulted in a complete abolishment of ANP action on
ICaL implying that the inhibitory effect of ANP was through the
cGMP/PDE2/cAMP pathway (Fig. 7B), and this was further
proved by the results of 8-bromo-cGMP (supplemental Fig. S2). In
the presence of L-NAME as well as of 1H-(1,2,4)oxadiazolo(4,3-
a)quinoxalin-1-one (ODQ) [27], however, ANP-still decreased
ICaL excluding a role of NO or sGC.
The evidence that ANP has a direct effect on ICaL in the heart is
controversial. Most studies suggest that ANP has a direct effect
only in the SA node in isolated atrial tissue preparations
[12,18,34,35]. Other reports support the notion that ANP has
no direct effect on action potential duration (APD) or contractility
Figure 7. PDE2-cAMP-PKA pathway of ANP depression on ICaL.A , time course of ICaL (a) shows ANP still inhibits the current in KT5823, a PKG
selective inhibitor, pre-treated myocytes in about 70% cells tested (b); Ac, density of peak ICaL. B, time course (a) demonstrates that ANP fails to
depress ICaL in the presence of EHNA, a PDE2 selective inhibitor, in almost all cells tested (b). Bc, density of peak ICaL. *P,0.05 compared with control.
doi:10.1371/journal.pone.0008847.g007
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ANP may not have a direct negative chronotropic effect, the
receptor linkage to the guanylyl cyclase in rabbit atrium [39],
rabbit [40] and rat ventricle [41,42], as well as rabbit Purkinje
fibers [43,44] has been proven. Moreover, ANP receptor
stimulation results in an increase of intracellular cGMP and
thereafter a decrease of cAMP levels [14]. These findings are well
in line with our results where the ANP effect in EDS cells was fully
mediated by a PDE-II mediated decrease of cAMP levels. The
negative chronotropic effect of ANP is in agreement with results
reported by Favaretto-AL and co-workers [45].
ANP has been demonstrated to exert an effect on both basal
ICaL as well as pre-stimulated ICaL. In human atrial cells, 10 nM
ANP reduces ICaL [12] which suggests that ANP-induced
inhibition of ICaL was via a cGMP-dependent mechanism [19].
Similar results have been found in chicken embryonic myocytes
[46] and in rabbit ventricular cells. Both cell types are
characterized by high intrinsic adenylyl cyclase activities. In rabbit
ventricular cells, ANP also produced a concentration-dependent
decrease of basal ICaL. This effect was blocked upon application of
8-bromo-cGMP, a non-metabolizable analog of cGMP. Single
channel recordings revealed that ANP reduces the open
probability of Ca
2+ channel without affecting the unitary
conductance [18]. The catecholamine-stimulated ICaL was also
attenuated by ANP. In human cardiomyocytes, ANP reduced
ISO-stimulated ICaL by 25% through a cGMP-dependent
mechanism [23]. Gisbert and Fischmeister [17] demonstrated
that ICaL was also inhibited by ANP in single frog ventricular
myocytes. They suggested that ANP had a direct G-protein
mediated effect on AC. However, we here demonstrate at least for
the EDS cells that ANP action is still preserved in PTX incubated
cells, but abolished after clamping cAMP levels.
It is known that ANP exerts its physiological and pathological role
via an increase of cellular cGMP levels [18] due to specific activation
of the particulate guanylyl cyclase [5]. Our previous data of ODQ as
well as MB excluded an involvement of the soluble guanylyl-cyclase
[27]. An involvement of PKG in the ANP-mediated depression of
ICaL was excluded for ES cell-derived cardiomyocytes since in the
presence of KT5823, a PKG selective inhibitor, ANP still inhibited
the ICaL (Fig. 7A), and clamping of cAMP-PKA levels abolished ICaL
depression. This is in clear contrast to a report [18], where ANP
decreased basal ICaL through intracellular production of cGMP and
activation of PKG in rabbit heart cells. Thus, we show that the
depression of ANP on ICaL is through the particulate GC, cGMP
a n dP D E 2m e d i a t e dd e p r e s s i o no fc A M P - P K A .
It has previously reported that another fragment of ANP,
ANP1–28, also possesses inhibitory effect on ICaL in rabbit heart
cells [18]. In the present study we also examined this fragment in
our models, and the results suggested that the inhibitory effect of
ANP1–28 on ICaL was weaker compared to that of ANP3–28. The
reason for the discrepancy between 3–28 ANP and 1–28 ANP was
unclear though the model difference might be one possible reason.
In conclusion, ANP depresses ICaL via pGC/cGMP and PDE2
mediated cAMP/PKA breakdown pathway in early developmen-
tal cardiomyocytes.
Supporting Information
Figure S1 Dose-response and inhibition of ANP on action
potentials. A, concentration-response relation between ANP and
the decrease in Ca
2+ current. B, action potentials were almost
completely inhibited by ANP (20 nM) if washout not followed.
Data are mean 6 s.e. mean. *P,0.05, **P,0.01.
Found at: doi:10.1371/journal.pone.0008847.s001 (0.92 MB TIF)
Figure S2 Effects of 8-Bromo-cGMP on L-type Ca
2+ current in
EDS cardiomyocytes. Time course of ICaL demonstrates that 8-
Bromo-cGMP (200 mM) depresses ICaL (A), and the effect of 8-
Bromo-cGMP on ICaL is abolished by pre-treatment of the cells
with EHNA, a specific inhibitor of PDE2 (B). C, percentage of cells
responding to 8-Bromo-cGMP. D, density of peak ICaL.
**P,0.01 compared with control.
Found at: doi:10.1371/journal.pone.0008847.s002 (0.70 MB TIF)
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